South & Central America Infusion Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The South and Central America infusion devices market is projected to grow significantly, reaching an estimated US$ 1,164.42 million by 2031, up from US$ 722.52 million in 2023, reflecting a compound annual growth rate (CAGR) of 6.1% during this period.

Executive Summary and Market Analysis

This market is divided into key regions: Brazil, Argentina, and the Rest of South and Central America. Brazil, in particular, has seen technological advancements that positively impact its economy, making it an attractive location for manufacturing due to benefits like cost-effectiveness and improved operational efficiencies. The infusion devices market in this region is characterized by numerous prominent players who are actively working to increase their market presence through strategic initiatives, including product innovation, partnerships, and regional expansion. Key companies in this sector include Abbott, B. Braun Melsungen AG, Baxter International Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medline Industries, Inc., and Medtronic. These firms are enhancing their product offerings and distribution networks to meet the rising demand for infusion devices. Notably, the insulin infusion pump segment is expected to grow at a CAGR of 6.3% from 2025 to 2030, driven by technological advancements, regulatory changes, and the increasing prevalence of chronic diseases, which boost the need for advanced infusion therapies.

Market Segmentation Analysis

The South and Central America infusion devices market can be segmented by product type, application, and end user.

Product Type: The market is divided into infusion pumps and infusion sets, with infusion pumps holding a larger market share in 2023. Within infusion pumps, volumetric pumps, syringe pumps, insulin pumps, patient-controlled analgesia (PCA) pumps, enteral pumps, implantable pumps, and elastomeric pumps are included, with volumetric pumps leading the market.
Infusion Sets: This segment is categorized into vented and non-vented infusion sets, where vented sets dominated in 2023.
Application: The market is segmented into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others, with diabetes being the largest segment in 2023.
End User: The end-user categories include hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others, with hospitals and specialty clinics holding the largest share.

Market Outlook

Market players are focusing on strategic developments such as product launches, mergers, acquisitions, and collaborations to create advanced products that facilitate the treatment of chronic conditions like diabetes, cancer, and chronic pain. Recent developments include:

In February 2023, Mindray introduced its BeneFusion i Series and u Series infusion systems, designed for high precision and medication safety across various clinical settings.
In March 2022, Fresenius Kabi received FDA clearance for its Agilia Connect Infusion System, which includes advanced volumetric and syringe pumps.
In January 2021, Eitan Medical launched operations in the UK to enhance support for its Sapphire infusion pump customers.

These advancements indicate a growing trend of product approvals and strategic collaborations, which are expected to create lucrative opportunities in the infusion devices market.

Country Insights

The market is primarily composed of Brazil, Argentina, and the Rest of South and Central America, with Brazil holding the largest market share in 2023. Brazil is among the top ten countries with the highest diabetes prevalence, affecting approximately 16.8 million individuals. This rising incidence of diabetes has led to a significant increase in cardiovascular disease risk, thereby driving the demand for infusion pumps. Local companies like Lifemed S.A. are also focusing on product development to enhance their market share alongside international competitors.

Company Profiles

Key players in the South and Central America infusion devices market include B Braun SE, Baxter International Inc, Becton Dickinson and Co, BPL Medical Technologies Pvt Ltd, CODAN US Corp, Eitan Medical Ltd, Fresenius Kabi AG, ICU Medical Inc, Medtronic Plc, and others. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to deliver innovative solutions and increase their market presence.

Reasons to buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America infusion devices market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America infusion devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America infusion devices market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution. Show more